Links to Data sources

Sr. No Display Name Type Country Last Updated
1 OPED Data Source Denmark 17/07/2020

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Renin-angiotensin-aldosterone system inhibitors and adverse outcomes of COVID-19: a Danish nationwide cohort study Professor Henrik Toft Sørensen 10/12/2020
Finalised Aclidinium Bromide Drug Utilisation Post-Authorisation Safety Studies (DUS): Common Protocol for Aclidinium (DUS1) and Aclidinium/Formoterol Fixed-Dose Combination (DUS2) Dr Cristina Rebordosa 08/12/2020
Finalised Post-Authorization Safety Program—Validation of the Danish Data Resources for the Study of Cardiovascular and Neoplasm Events in Users of Treatments for Overactive Bladder Dr Alejandro Arana 10/04/2019
Finalised Evaluation of potential off-label use of dabigatran etexilate in Europe Dr Manel Pladevall-Vila 20/09/2018
Finalised Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids Dr Jordi Castellsague 15/05/2018
Finalised Evaluation of the Use of Nepafenac in Selected European Populations Dr Alejandro Arana Navarro 25/07/2017
Ongoing Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection Professor Anton Pottegård 30/11/2020
Ongoing The effect of mental disorders and treatment with psychotropic agents on the course of COVID-19 Dr Christiane Gasse 28/10/2020
Ongoing Impact of use of newer glucose lowering drugs on outcomes in patients with COVID-19 Dr Simone Bastrup Israelsen 09/09/2020
Ongoing Impact of use of proton pump inhibitors on susceptibility to infection and risk of hospitalisation in patients with COVID-19 Dr Simone Bastrup Israelsen 04/09/2020
Ongoing The prognosis of coronavirus disease (COVID-19) in patients recently treated with immunosuppressant medications. Professor Jesper Hallas 20/08/2020
Ongoing Risk and course of COVID-19 infection in patients with hypo- or hyperthyroidism. A Danish population-based cohort study Professor Jesper Hallas 19/08/2020
Ongoing Inhaled corticosteroids and COVID-19 morbidity: Nationwide cohort study Mr Anders Husby 06/07/2020
Ongoing Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study Professor Anton Pottegård 21/04/2020
Planned NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of Ozempic® (semaglutide s.c.) in patients with type 2 diabetes- A cohort study based on Nordic registry data Professor Anton Pottegård 24/11/2020
Planned Drug-drug interactions between dicloxacillin/flucloxacillin and DOACs Professor Anton Pottegård 16/11/2020
Planned The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases Professor Jesper Hallas 07/10/2020